Gne Myopathy
📧 Sign up to get email alerts when something new happens for Gne Myopathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Natural History Study of Patients With GNE Myopathy and GNE-Related Diseases
A completed natural history observational study of patients with GNE myopathy and related GNE disorders.
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: First-in-human Study of UX016 in GNEM [Phase 1, Phase 2]
Update on a first-in-human study of UX016 for GNE myopathy (GNEM) in Phase 1/2, currently not recruiting.
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: Multi-Center Study of ManNAc for GNE Myopathy [Phase 2]
A Phase 2 multi-center trial evaluating ManNAc for GNE myopathy is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2022-05-16Clinical Trial Update: Efficacy Confirmation Study of NPC-09 [Phase 3]
Phase 3 efficacy confirmation study for NPC-09 in GNE myopathy and related distal myopathies has completed.
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: An Open Label Phase 2 Study of ManNAc in Subjects With GNE Myopathy [Phase 2]
Phase 2 open-label trial of ManNAc in GNE myopathy completed; results posted in 2019.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-02-19Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Aceneuramic Acid Extended-Release (Ace-ER) Tablets in Patients With Glucosamine (UDP-N-acetyl)-2-epimerase Myopathy (GNEM) or Hereditary Inclusion Body Myopathy (HIBM) [Phase 3]
Phase 3 trial evaluating Ace-ER in GNEM/HIBM was terminated; results were posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-02-19Clinical Trial Update: A Study to Evaluate the Safety of Aceneuramic Acid Extended Release (Ace-ER; UX001) Tablets in Glucosamine (UDP-N-acetyl)-2-Epimerase (GNE) Myopathy (GNEM) (Also Known as Hereditary Inclusion Body Myopathy [HIBM]) Patients With Severe Ambulatory Impairment [Phase 2]
The Phase 2 trial of Aceneuramic Acid Extended Release (Ace-ER; UX001) tablets for patients with GNE myopathy was terminated, with results p…
-
CLINICAL_TRIALS trial_result · 2018-07-09Clinical Trial Update: Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Sialic Acid in Patients With Glucosamine (UDP-N-acetyl)-2-epimerase Myopathy (GNEM) or Hereditary Inclusion Body Myopathy (HIBM) [Phase 3]
A Phase 3 randomized, double-blind, placebo-controlled study evaluating sialic acid in GNEM/HIBM (GNE myopathy) has completed with results p…
-
CLINICAL_TRIALS research · 2018-04-27Clinical Trial Update: GNE-Myopathy Disease Monitoring Program (GNEM-DMP): A Registry and Prospective Observational Natural History Study to Assess GNE Myopathy or Hereditary Inclusion Body Myopathy (HIBM)
This clinical trial update describes Ultragenyx's GNE-Myopathy Disease Monitoring Program, a registry and prospective natural history study.…
-
CLINICAL_TRIALS trial_result · 2018-03-13Clinical Trial Update: An Open Label Phase 2 Extension Study of Higher Dose Sialic Acid-Extended Release (SA-ER) Tablets and Sialic Acid-Immediate Release (SA-IR) Capsules in Patients With Glucosamine (UDP-N-acetyl)-2-Epimerase (GNE) Myopathy [Phase 2]
Open-label Phase 2 extension study evaluating higher-dose sialic acid formulations (SA-ER and SA-IR) in GNE myopathy; study completed with r…
-
CLINICAL_TRIALS trial_result · 2017-10-19Clinical Trial Update: Phase I Clinical Trial of ManNAc in Patients With GNE Myopathy or Hereditary Inclusion Body Myopathy (HIBM) [Phase 1]
Phase I trial of ManNAc (N-acetylmannosamine) in patients with GNE myopathy and hereditary inclusion body myopathy has completed.
-
CLINICAL_TRIALS trial_result · 2016-06-16Clinical Trial Update: A Phase 2 Study to Evaluate the Dose and Pharmacodynamic Efficacy of Sialic Acid-Extended Release (SA-ER) Tablets in Patients With GNE Myopathy or Hereditary Inclusion Body Myopathy [Phase 2]
Phase 2 trial evaluating dose and pharmacodynamic efficacy of Sialic Acid-Extended Release (SA-ER) tablets in patients with GNE myopathy or …